Form D · Private Equity Fund
Sands Capital Life Sciences Pulse Opportunities Fund, L.P.
Arlington, VA · CIK 0001890688
Offering snapshot reported Nov 7, 2023 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 7, 2023 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Nov 7, 2022 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Nov 12, 2021 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06c, 3C, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-420854
Source: Form D, filed Nov 7, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ian Ratcliffe | Executive |
| Stephen Zachary | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
C/O Sands Capital Ventures, Llc 1000 Wilson Blvd., Suite 3000
Arlington, VA, 22209
Arlington, VA, 22209